Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.

Simple item page
dc.contributor.authorChakrabarti, Sen_US
dc.contributor.authorPradhan, Pen_US
dc.contributor.authorRoy, Aen_US
dc.contributor.authorHira, Men_US
dc.contributor.authorBandyopadhyay, Gen_US
dc.contributor.authorBhattacharya, D Ken_US
dc.date.accessioned2006-01-30en_US
dc.date.accessioned2009-06-01T10:24:01Z
dc.date.available2006-01-30en_US
dc.date.available2009-06-01T10:24:01Z
dc.date.issued2006-01-30en_US
dc.description.abstractAlong with hepatitis B virus (HBV) and human immunodeficiency virus (HIV), Hepatitis C virus (HCV) is emerging as a major transfusion hazard. 22 cases of haemophilia (A 19, B 3) and 20 cases of thalassaemia (2 16, E(2) 4) constituted the study group. Patients tested for anti HCV (using third generation ELISA), HBsAg and antibodies to HIV I and II. Prevalence of anti HCV was 54.5% in haemophilics and 5% in thalassaemics. HBsAg was detected in 9.09% haemophilics and 5% thalassaemics. No anti HIV was detected in this cohort. Anti HCV seropositivity in haemophilics has increased compare to previous studies.en_US
dc.description.affiliationDept. of Pathology, NRS Medical College. sudiptach@gmail.comen_US
dc.identifier.citationChakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian Journal of Public Health. 2006 Jan-Mar; 50(1): 43-4en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/109820
dc.language.isoengen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshAntibodies, Viral --blooden_US
dc.subject.meshBlood Transfusion --adverse effectsen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshHIV --immunologyen_US
dc.subject.meshHemophilia A --therapyen_US
dc.subject.meshHepacivirus --immunologyen_US
dc.subject.meshHepatitis B Surface Antigens --blooden_US
dc.subject.meshHepatitis C --transmissionen_US
dc.subject.meshHumansen_US
dc.subject.meshPrevalenceen_US
dc.subject.meshSeroepidemiologic Studiesen_US
dc.subject.meshThalassemia --therapyen_US
dc.titlePrevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Public Health